Objective An unknown portion of women with silicone breast implants (SBI) report
development of systemic symptoms, recently named as 'breast implant illness (BII)'. We aim …

The incidence of breast implants and silicone injections has continuously increased since
their FDA approval for use in the 1960′ s. The prevalence of overall adverse events is …

Background and Objectives: Since silicone breast implants were introduced to the market
several decades ago, the safety of breast implants has remained controversial. Recently …

Author links open overlay panel CA Bargon ab, BE Becherer cd, DA Young-Afat e, ACM van
Bommel f, J Hommes g, MJ Hoornweg h, XHA Keuter g, S de Fazio i, D Melnikov j, J Monton …

Summary Background The Australian Breast Device Registry (ABDR) is a clinical quality
registry designed to monitor the performance of breast devices; and the quality and safety of …

Background In 2014, the hyaluronic acid-based fillers, Hyacorp-1000 and Hyacorp HS (H-
800), were withdrawn from the Dutch market after concerns about their safety Objectives To …

Background There has been a growing concern about a possible causal relationship
between silicone breast implants (SBIs) and health symptoms, referred to as breast implant …

Background Explantation is the proposed treatment for breast implant illness (BII). Little is
known about which medical specialists are visited and what diagnoses are made before …

Introduction Implant loss following breast reconstruction is a devastating complication, which
should be prevented as much as possible. This study aimed to validate a previously …

Background: Knowledge about the prevalence of women with breast implants is paramount
in calculations of risks and in estimations of effects on screening and breast cancer …